Vanguard Group’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $17.9M | Sell |
5,028,534
-75,976
| -1% | -$465K | ﹤0.01% | 2662 |
|
|
2025
Q3 | $45.4M | Sell |
5,104,510
-2,357
| -0% | -$23.9K | ﹤0.01% | 2201 |
|
|
2025
Q2 | $47.1M | Buy |
5,106,867
+204,621
| +4% | +$1.75M | ﹤0.01% | 2147 |
|
|
2025
Q1 | $42.1M | Buy |
4,902,246
+221,802
| +5% | +$2.09M | ﹤0.01% | 2162 |
|
|
2024
Q4 | $50.3M | Sell |
4,680,444
-59,727
| -1% | -$459K | ﹤0.01% | 2157 |
|
|
2024
Q3 | $26.9M | Buy |
4,740,171
+191,952
| +4% | +$1.11M | ﹤0.01% | 2449 |
|
|
2024
Q2 | $19.2M | Buy |
4,548,219
+133,537
| +3% | +$540K | ﹤0.01% | 2595 |
|
|
2024
Q1 | $22.5M | Buy |
4,414,682
+54,034
| +1% | +$304K | ﹤0.01% | 2545 |
|
|
2023
Q4 | $40.6M | Buy |
4,360,648
+115,304
| +3% | +$794K | ﹤0.01% | 2276 |
|
|
2023
Q3 | $27.8M | Buy |
4,245,344
+41,193
| +1% | +$328K | ﹤0.01% | 2406 |
|
|
2023
Q2 | $34.2M | Buy |
4,204,151
+33,547
| +0.8% | +$287K | ﹤0.01% | 2359 |
|
|
2023
Q1 | $35.7M | Buy |
4,170,604
+26,104
| +0.6% | +$261K | ﹤0.01% | 2329 |
|
|
2022
Q4 | $38.4M | Buy |
4,144,500
+38,505
| +0.9% | +$411K | ﹤0.01% | 2317 |
|
|
2022
Q3 | $42.4M | Buy |
4,105,995
+119,684
| +3% | +$1.26M | ﹤0.01% | 2267 |
|
|
2022
Q2 | $39.9M | Buy |
3,986,311
+101,870
| +3% | +$965K | ﹤0.01% | 2298 |
|
|
2022
Q1 | $47.8M | Buy |
3,884,441
+42,871
| +1% | +$527K | ﹤0.01% | 2329 |
|
|
2021
Q4 | $66.6M | Sell |
3,841,570
-149,802
| -4% | -$2.85M | ﹤0.01% | 2194 |
|
|
2021
Q3 | $71.6M | Buy |
3,991,372
+343,379
| +9% | +$6.83M | ﹤0.01% | 2168 |
|
|
2021
Q2 | $83.4M | Buy |
3,647,993
+254,335
| +7% | +$3.77M | ﹤0.01% | 2089 |
|
|
2021
Q1 | $50.7M | Buy |
3,393,658
+496,767
| +17% | +$5.43M | ﹤0.01% | 2307 |
|
|
2020
Q4 | $15.6M | Buy |
2,896,891
+133,009
| +5% | +$701K | ﹤0.01% | 2760 |
|
|
2020
Q3 | $12.6M | Buy |
2,763,882
+240,693
| +10% | +$1.04M | ﹤0.01% | 2675 |
|
|
2020
Q2 | $12.4M | Buy |
2,523,189
+62,806
| +3% | +$237K | ﹤0.01% | 2659 |
|
|
2020
Q1 | $7.75M | Buy |
2,460,383
+25,792
| +1% | +$89.9K | ﹤0.01% | 2736 |
|
|
2019
Q4 | $6.31M | Sell |
2,434,591
-4,889
| -0.2% | -$12.8K | ﹤0.01% | 3087 |
|
|
2019
Q3 | $7.71M | Buy |
2,439,480
+448,806
| +23% | +$1.3M | ﹤0.01% | 2955 |
|
|
2019
Q2 | $6.71M | Buy |
1,990,674
+1,178,831
| +145% | +$3.66M | ﹤0.01% | 3063 |
|
|
2019
Q1 | $2.48M | Buy |
811,843
+171,389
| +27% | +$409K | ﹤0.01% | 3381 |
|
|
2018
Q4 | $999K | Sell |
640,454
-1,016,685
| -61% | -$2.31M | ﹤0.01% | 3566 |
|
|
2018
Q3 | $4.52M | Sell |
1,657,139
-35,000
| -2% | -$98.7K | ﹤0.01% | 3274 |
|
|
2018
Q2 | $4.43M | Sell |
1,692,139
-77,288
| -4% | -$216K | ﹤0.01% | 3250 |
|
|
2018
Q1 | $4.88M | Buy |
1,769,427
+35,352
| +2% | +$99.9K | ﹤0.01% | 3165 |
|
|
2017
Q4 | $5.58M | Buy |
1,734,075
+77,560
| +5% | +$305K | ﹤0.01% | 3089 |
|
|
2017
Q3 | $6.86M | Buy |
1,656,515
+38,758
| +2% | +$172K | ﹤0.01% | 2988 |
|
|
2017
Q2 | $8.61M | Buy |
1,617,757
+132,076
| +9% | +$763K | ﹤0.01% | 2852 |
|
|
2017
Q1 | $8.53M | Buy |
1,485,681
+171,577
| +13% | +$886K | ﹤0.01% | 2829 |
|
|
2016
Q4 | $5.2M | Buy |
1,314,104
+114,943
| +10% | +$409K | ﹤0.01% | 3048 |
|
|
2016
Q3 | $4.35M | Buy |
1,199,161
+30,148
| +3% | +$127K | ﹤0.01% | 3074 |
|
|
2016
Q2 | $7.14M | Buy |
1,169,013
+164,686
| +16% | +$796K | ﹤0.01% | 2806 |
|
|
2016
Q1 | $4.92M | Buy |
1,004,327
+543,507
| +118% | +$2.39M | ﹤0.01% | 2963 |
|
|
2015
Q4 | $2.57M | Buy |
+460,820
| New | +$3.28M | ﹤0.01% | 3293 |
|
Other funds holding AVXL
NL
SF
